Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cara Therapeutics Inc (NASDAQ: CARA) closed the day trading at $0.28 down -0.14% from the previous closing price of $0.28. In other words, the price has decreased by -$0.14 from its previous closing price. On the day, 0.66 million shares were traded. CARA stock price reached its highest trading level at $0.2799 during the session, while it also had its lowest trading level at $0.2571.
Ratios:
For a better understanding of CARA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.48 and its Current Ratio is at 4.59. In the meantime, Its Debt-to-Equity ratio is 4.07 whereas as Long-Term Debt/Eq ratio is at 4.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on June 13, 2024, Downgraded its rating to Hold and sets its target price to $1 from $6 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 01 ’24 when Posner Christopher sold 4,149 shares for $0.35 per share. The transaction valued at 1,452 led to the insider holds 172,436 shares of the business.
Posner Christopher sold 3,936 shares of CARA for $2,952 on May 02 ’24. The PRESIDENT AND CEO now owns 176,585 shares after completing the transaction at $0.75 per share. On Apr 05 ’24, another insider, Goncalves Joana, who serves as the CHIEF MEDICAL OFFICER of the company, sold 2,753 shares for $0.83 each. As a result, the insider received 2,285 and left with 53,365 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CARA now has a Market Capitalization of 15115722 and an Enterprise Value of 5661733. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.37 while its Price-to-Book (P/B) ratio in mrq is 1.30. Its current Enterprise Value per Revenue stands at 0.515 whereas that against EBITDA is -0.054.
Stock Price History:
Over the past 52 weeks, CARA has reached a high of $1.68, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is -14.76%, while the 200-Day Moving Average is calculated to be -51.38%.
Shares Statistics:
Over the past 3-months, CARA traded about 540.78K shares per day on average, while over the past 10 days, CARA traded about 288070 shares per day. A total of 54.48M shares are outstanding, with a floating share count of 45.76M. Insiders hold about 16.57% of the company’s shares, while institutions hold 32.32% stake in the company. Shares short for CARA as of 1726185600 were 1207225 with a Short Ratio of 2.23, compared to 1723680000 on 1458611. Therefore, it implies a Short% of Shares Outstanding of 1207225 and a Short% of Float of 2.56.
